Dear Madam/Sir
As the authors of the two below mentioned papers we would like to state that the “science” on which the FDA policy on sodium reduction is based is dubious. This truth is already unmistakable now for most interested scientists and sooner or later it will be clear also to laymen. When this happens there will be responsible persons who would have a problem as the present recommendations may kill people instead of saving them. We therefore suggest that FDA, instead of considering how to reduce the sodium intake in the population, reconsiders the policy. In the attached paper we have argued for this position.
Sincerely
Niels Graudal
Gesche Jürgens
1) Graudal NA, Galloe AG, Garred P. Effects of sodium restriction on blood pressure, renin, aldosterone, catecholamines, cholesterols, and triglyceride, A meta-analysis. JAMA 1998; 279: 1383-1391.
2) Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev 2011; (11):CD004022.)
Comment from Niels Graudal
This is comment on Notice
Meetings: Approaches to Reducing Sodium Consumption
View Comment
Attachments:
Graudal-J�rgens. FDA commentary 281111
Title:
Graudal-J�rgens. FDA commentary 281111
Related Comments
Public Submission Posted: 11/03/2011 ID: FSIS-2011-0014-0037
Nov 29,2011 11:59 PM ET
Public Submission Posted: 11/28/2011 ID: FSIS-2011-0014-0128
Nov 29,2011 11:59 PM ET
Public Submission Posted: 11/28/2011 ID: FSIS-2011-0014-0129
Nov 29,2011 11:59 PM ET